Aspirin use is associated with reduced risk for hepatocellular carcinoma.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 35785535.
- Also identified by DOI 10.7326/J22-0049.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Wang Y, Wang M, Liu C, et al. <b>Aspirin use and the risk of hepatocellular carcinoma: a meta-analysis.</b> J Clin Gastroenterol. 2022. [Epub ahead of print.] 35316225.
Medical subject headings
- Carcinoma, Hepatocellular
- Liver Neoplasms